PL3675872T3 - Kompozycje zapewniające poprawę komfortu oczu - Google Patents

Kompozycje zapewniające poprawę komfortu oczu

Info

Publication number
PL3675872T3
PL3675872T3 PL18773265.6T PL18773265T PL3675872T3 PL 3675872 T3 PL3675872 T3 PL 3675872T3 PL 18773265 T PL18773265 T PL 18773265T PL 3675872 T3 PL3675872 T3 PL 3675872T3
Authority
PL
Poland
Prior art keywords
providing improved
compositions providing
improved eye
eye comfort
comfort
Prior art date
Application number
PL18773265.6T
Other languages
English (en)
Inventor
Mingqi Bai
Kenneth T. Holeva
Original Assignee
Johnson & Johnson Surgical Vision, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Surgical Vision, Inc. filed Critical Johnson & Johnson Surgical Vision, Inc.
Publication of PL3675872T3 publication Critical patent/PL3675872T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL18773265.6T 2017-08-30 2018-08-29 Kompozycje zapewniające poprawę komfortu oczu PL3675872T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762552066P 2017-08-30 2017-08-30
US16/113,073 US11129862B2 (en) 2017-08-30 2018-08-27 Ophthalmic compositions
PCT/IB2018/056592 WO2019043596A1 (en) 2017-08-30 2018-08-29 Compositions providing improved eye comfort

Publications (1)

Publication Number Publication Date
PL3675872T3 true PL3675872T3 (pl) 2024-09-09

Family

ID=65436610

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18773265.6T PL3675872T3 (pl) 2017-08-30 2018-08-29 Kompozycje zapewniające poprawę komfortu oczu

Country Status (8)

Country Link
US (2) US11129862B2 (pl)
EP (1) EP3675872B1 (pl)
JP (2) JP7091444B2 (pl)
KR (1) KR102603837B1 (pl)
CN (1) CN111050777B (pl)
AU (1) AU2018323035B2 (pl)
PL (1) PL3675872T3 (pl)
WO (1) WO2019043596A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
JPS5318520B2 (pl) 1972-07-05 1978-06-15
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4328803B1 (en) 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
JPS5945890A (ja) 1982-09-09 1984-03-14 Toyo Jozo Co Ltd 新規抗生物質アクミマイシンおよびその製造法
US5316926A (en) 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5202431A (en) 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
SE9401806D0 (sv) 1994-05-26 1994-05-26 Pharmacia Ab Method and means for the production of hyaluronic acid
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
JP2000060487A (ja) 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
RU2005102604A (ru) 2002-07-03 2005-09-10 Перикор Сайенс, Инк. (Us) Композиция гиалуроновой кислоты и способы применения
TWI434926B (zh) 2006-12-11 2014-04-21 Alcon Res Ltd 眼用組成物中聚氧化乙烯-聚氧化丁烯（ｐｅｏ-ｐｂｏ）嵌段共聚物之使用
ZA200904917B (en) * 2007-02-09 2010-09-29 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
WO2008137863A2 (en) 2007-05-04 2008-11-13 Advanced Medical Optics, Inc. Methods and devices for measuring tear film and diagnosing tear disorders
PL2011486T5 (pl) 2007-07-06 2016-09-30 Lupin Ltd Farmaceutyczne kompozycje rifaksyminy
WO2009008005A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
ITRM20070510A1 (it) 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
AU2010365779B2 (en) 2010-12-23 2015-07-23 Colgate-Palmolive Company Fluid compositions comprising a structuring agent
ITMI20110583A1 (it) 2011-04-08 2012-10-09 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
US8865685B2 (en) 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
CA2946373C (en) 2014-05-01 2018-07-31 Integral Biosystems Llc Membrane-adherent self-assembled systems for treatment of ocular disorders
GB2541840B (en) 2014-06-20 2017-09-06 Coopervision Int Holding Co Lp Ophthalmic composition for the treatment of ocular infection
CN105342873A (zh) * 2015-11-02 2016-02-24 上海韵宜生物科技有限公司 一种新型护肤凝胶及其制备方法和应用
US10632202B2 (en) * 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
US11166997B2 (en) * 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Also Published As

Publication number Publication date
JP7358526B2 (ja) 2023-10-10
KR102603837B1 (ko) 2023-11-21
RU2020112099A3 (pl) 2021-09-30
US20210401919A1 (en) 2021-12-30
WO2019043596A1 (en) 2019-03-07
US11129862B2 (en) 2021-09-28
CN111050777B (zh) 2023-05-02
US20190060385A1 (en) 2019-02-28
JP2020532527A (ja) 2020-11-12
AU2018323035A1 (en) 2020-02-27
WO2019043596A9 (en) 2024-04-04
EP3675872A1 (en) 2020-07-08
JP7091444B2 (ja) 2022-06-27
RU2020112099A (ru) 2021-09-30
JP2022058994A (ja) 2022-04-12
AU2018323035B2 (en) 2024-04-04
EP3675872B1 (en) 2024-06-05
CN111050777A (zh) 2020-04-21
KR20200044847A (ko) 2020-04-29

Similar Documents

Publication Publication Date Title
DK3665237T3 (en) Compositions
PT3426226T (pt) Composição oftalmológica
GB2556619B (en) Suspension compositions
PL3373973T3 (pl) Kompozycje do oczu
PL3250185T3 (pl) Oftalmiczna kompozycja zawiesinowa
GB201619525D0 (en) Ophthalmic composition
GB201719480D0 (en) Compositions
SG11201707117SA (en) Ophthalmic composition
GB201707909D0 (en) Compositions
GB201707462D0 (en) Ocular compositions
GB201604249D0 (en) Improved hydrophilic compositions
DK3573468T3 (en) Fat Composition
GB201707454D0 (en) Compositions
PL3609464T3 (pl) Kompozycje na bazie ksantohumolu
GB2563911B (en) Comfort aid
DK3582624T3 (en) Fat composition
PL3675872T3 (pl) Kompozycje zapewniające poprawę komfortu oczu
GB2570376B (en) Suspension compositions
IL269120A (en) Compositions comprising avelumab
GB201717712D0 (en) Compositions
GB201703136D0 (en) Compositions
PL3508211T3 (pl) Kompozycja dla zdrowia oczu
GB2568650B (en) Comfort damper
GB201717528D0 (en) Comfort damper
GB201713226D0 (en) Compositions